Come up with a name for your new list and we'll add to it:
Xeris Pharmaceuticals raised a round of funding on December 12, 2011. Investors include
Central Texas Angel Network.
Xeris is a specialty biopharmaceutical company focused on developing improved and differentiated injectable therapeutics for multiple indications in diabetes, epilepsy, and immunology. The company's X…